Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

Abstract Background Data on the prevalence of perennial versus seasonal allergic asthma in Italy are lacking; moreover, there is limited evidence on the effect of omalizumab on patient-reported outcomes in Italian patients with severe allergic asthma. PROXIMA, an observational, multicenter study, wa...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Giorgio Walter Canonica, Paola Rottoli, Caterina Bucca, Maria Cristina Zappa, Giovanni Michetti, Bruno Macciocchi, Cristiano Caruso, Pierachille Santus, Marta Bartezaghi, Laura Rigoni, on behalf of PROXIMA study centers
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2018-11-01
Reeks:	World Allergy Organization Journal
Onderwerpen:	Omalizumab Severe allergic asthma Asthma control Exacerbations Quality of life Perennial allergens
Online toegang:	http://link.springer.com/article/10.1186/s40413-018-0214-3
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!